Ayla Annac | CEO & Co-Founder, InvivoSciences – Precision Medicine for Heart Failure and Cardiometabolic Diseases

from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Ayla Annac, CEO and Co-Founder of InvivoSciences, a precision medicine company transforming the way therapies are discovered and developed for heart failure and cardiometabolic diseases. Ayla shares insights into InvivoSciences’ innovative platform, the promise of patient-specific models in drug discovery, and the company’s vision for advancing precision medicine.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on April 11, 2025.

Episode metadata supplied by the publisher feed · Published Sep 8, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Ayla Annac | CEO & Co-Founder, InvivoSciences – Precision Medicine for Heart Failure and Cardiometabolic Diseases

0:00 40:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Executive Insights for Life Sciences Innovators?

This episode is 40 minutes long.

When was this Executive Insights for Life Sciences Innovators episode published?

This episode was published on September 8, 2025.

Can I download this Executive Insights for Life Sciences Innovators episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!